Utrecht University has criticized associate professor of pharmacology Joris Verster for insufficient transparency regarding commercial consultancy work that overlapped with his academic research on hangover cures and energy drink impacts.
While the university had granted Verster permission to perform external consulting, officials determined that he failed to adequately disclose the full scope of these commercial activities when presenting himself as an academic researcher.
>>> Nelly Korda Targets Career Grand Slam at British Open
Verster conducted studies through his sole proprietorship, NeuroClinics, evaluating a hangover prevention drug developed by Sen-Jam Pharmaceuticals.
His conclusions downplayed fears that such remedies would encourage excessive alcohol consumption based on survey data collected from students.
"Three-quarters of the young people surveyed said they would use the drug, and the majority also indicated that they would not drink more," said Verster.
Experts in medical ethics and research methodology questioned the validity and independence of those findings.
Frits Rosendaal, a professor of epidemiology at Leiden University Medical Center, stated in Trouw that questionnaire responses are insufficient to predict real-world actions.
"A questionnaire provides no conclusive evidence at all about how people will behave in the future," said Rosendaal.
The methodology also drew criticism from ethics experts who argued that institutional credibility was misused for commercial interests.
Mariëtte van den Hoven, a professor of medical ethics at Amsterdam UMC, highlighted the ethical breach caused by mixing academic and private roles.
"Where you use the university to promote your personal goals," said van den Hoven.
